These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21318586)

  • 21. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics.
    Zhu HM; Gu JH; Xie Y; Xie B; Ling JJ
    J Drug Target; 2018 Apr; 26(4):345-356. PubMed ID: 28920483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
    Huang CS; Zhai JM; Zhu XX; Cai JP; Chen W; Li JH; Yin XY
    Dig Dis Sci; 2017 Dec; 62(12):3501-3510. PubMed ID: 29098552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.
    Chen JJ; Cai N; Chen GZ; Jia CC; Qiu DB; Du C; Liu W; Yang Y; Long ZJ; Zhang Q
    Oncotarget; 2017 Mar; 8(11):17593-17609. PubMed ID: 26061710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin.
    Xia H; Cao J; Li Q; Lv Y; Jia W; Ren W; Cheng Q; Song X; Xu G
    Sci Rep; 2016 Oct; 6():34856. PubMed ID: 27725724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The search for cancer stem cells in hepatocellular carcinoma.
    Kamohara Y; Haraguchi N; Mimori K; Tanaka F; Inoue H; Mori M; Kanematsu T
    Surgery; 2008 Aug; 144(2):119-24. PubMed ID: 18656616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.
    Xu XL; Xing BC; Han HB; Zhao W; Hu MH; Xu ZL; Li JY; Xie Y; Gu J; Wang Y; Zhang ZQ
    Carcinogenesis; 2010 Feb; 31(2):167-74. PubMed ID: 19897602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells.
    Wang R; Chen S; Li C; Ng KT; Kong CW; Cheng J; Cheng SH; Li RA; Lo CM; Man K; Sun D
    BMC Cancer; 2016 Feb; 16():56. PubMed ID: 26846780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of hydroxycamptothecin on laryngeal squamous carcinoma cell line].
    Chai LP; Su ZZ; Xian ZX
    Ai Zheng; 2003 Apr; 22(4):372-5. PubMed ID: 12703991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-XL small interfering RNA enhances sensitivity of Hepg2 hepatocellular carcinoma cells to 5-fluorouracil and hydroxycamptothecin.
    Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
    Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):704-10. PubMed ID: 17033717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
    Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
    J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs.
    Xu Y; Xie Y; Wang X; Chen X; Liu Q; Ying M; Zheng Q
    Oncol Rep; 2013 Nov; 30(5):2056-62. PubMed ID: 24002436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
    Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Kawano T; Yonezawa H; Rokutanda S; Naruse T; Umeda M
    Oral Oncol; 2011 Sep; 47(9):855-60. PubMed ID: 21757396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response.
    Kato K; Kuhara A; Yoneda T; Inoue T; Takao T; Ohgami T; Dan L; Kuboyama A; Kusunoki S; Takeda S; Wake N
    Mol Cancer Ther; 2011 Aug; 10(8):1430-9. PubMed ID: 21632462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
    Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
    J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.
    Ling YH; Tseng MT; Nelson JA
    Differentiation; 1991 Mar; 46(2):135-41. PubMed ID: 1648523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
    Wei Z; Wang Y; Yu X; Zhang S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.